• OPEN AN ACCOUNT
Indian Indices
Nifty
25,285.35 103.55
(0.41%)
Sensex
82,500.82 328.72
( 0.40%)
Bank Nifty
56,609.75 417.70
( 0.74%)
Nifty IT
35,609.05 -19.45
( -0.05%)
Global Indices
Nasdaq
45,502.84 -876.59
(-1.89%)
Dow Jones
6,574.01 -182.10
(-2.70%)
Hang Seng
48,192.70 -387.74
(-0.80%)
Nikkei 225
9,427.47 -81.93
(-0.86%)
Forex
USD-INR
88.81 0.04
(0.05%)
EUR-INR
103.01 -0.16
(-0.15%)
GBP-INR
118.58 -0.38
(-0.32%)
JPY-INR
0.58 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
159.38
35.57
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

Ester Inds gains after board approves incorporation of WOS in USA
Sep 12,2025
The subsidiary will focus on marketing, supporting overseas customers, exploring new business opportunities, undertaking value-added manufacturing, and carrying out other permissible business activities.

The company will provide further updates once the subsidiary is formally incorporated, pending all necessary approvals from relevant governmental, regulatory, and statutory authorities in both India and the USA.

The initial capital investment for the subsidiary will be in cash, with the cost of acquisition not exceeding $ 1.5 million.

Ester Industries is one of India’s leading manufacturers of Polyester Films and Specialty Polymers having a track record of nearly four decades of continually developing new and innovative products for customers across the globe.

The company reported consolidated net loss of Rs 7.16 crore in Q1 FY26 as compared to net loss of Rs 16.10 crore reported in Q1 FY25. Revenue from operations rose 18.2% YoY to Rs 338.20 crore in Q1 FY26.